An artificial intelligence (AI) research project is playing a pivotal role in pandemic public health decision-making in several countries across Africa. IDRC is working with research teams that include the leaders of national taskforces, who help to ensure that research is turned into action.
In March 2020, the World Health Organization declared a pandemic due to the emergence of SARS-CoV2, which causes COVID-19, a potentially lethal respiratory infection. To date, apart from the novel Molnupiravir and Ritonavir, there are no orally or nasally administered antiviral agents to prevent or treat SARS-CoV2 infections.
With funding from IDRC, a research team from the Prospective Urban Rural Epidemiology (PURE) study, a large international population research effort coordinated by McMaster University’s Population Health Research Institute (PHRI), is studying why some people get COVID-19 and others do not.
Since 2016, a research team of senior and emerging African and Canadian researchers from the University of Malawi and the University of British Columbia (UBC), working in collaboration with Malawi’s Ministry of Health, has been exploring how to improve the use of proven ways to help save these babies’ lives.
Artificial intelligence (AI) and data science are key tools to support public health responses to COVID-19. IDRC and the Swedish International Development Cooperation Agency (Sida) are providing up to CA$10 million to support AI and data research and innovations in the Global South to assist the COVID-19 pandemic response and recovery.
Together with the Global Partnership for Education (GPE), IDRC has awarded CA$11.1 million to four regional learning partners who will design and operate hubs for the Knowledge and Innovation Exchange (KIX).